The assessment indicators are being developed!

On July 8, the State Council Information Office held a regular policy briefing to introduce the key tasks of deepening the reform of the medical and health system in 2021
.

As one of the key tasks of the medical reform in 2021, the medical reform experience of Sanming City will be further promoted, and the joint reform of medical care, medical insurance and medicine will be accelerated

Prior to this, on the afternoon of July 6, the Secretariat of the Medical Reform Leading Group of the State Council and the National Health Commission held a press conference on promoting the experience of Sanming's medical reform
.

At the press conference, questions about the "Essence of Sanming Medical Reform" were answered in detail, and it was revealed that public hospitals' remuneration system reform guidelines will be officially issued

From this point of view, the nationwide promotion of Sanming’s medical reform experience is firmly established.
What impact will this have on the pharmaceutical industry?

Select key indicators for regular evaluation

The key principle of the Sanming Medical Reform is "total fund contracting", that is, the medical insurance fund is paid in a package, and the medical insurance fund is "total contracted, overexpenditure is not covered, and the balance is retained".
In hospitals, the medical insurance fund with a certain balance can be directly included in medical income, and the enthusiasm of medical staff can be mobilized by deepening the reform of the salary system
.

At the same time, the operational risks of the medical insurance fund are transferred to the general hospital.

The industry generally believes that the Sanming medical reform is to return medicines to the function of treating diseases and to allow doctors to return to the role of seeing a doctor.
The "reform" provides more health "dividends", reduces the burden on the masses, increases the income of medical staff, and achieves a win-win situation for all parties
.

It is understood that since 2013, Sanming City has adjusted the prices of medical service items 9 times, transferring and increasing hospital medical income by 5.
739 billion yuan
.

In the total expenditure on medical treatment, the proportion of doctors’ medical expenses, medicine expenses, and inspection expenses will be adjusted and optimized from 18:60:22 in 2011 to 41:33:26 in 2020.

On July 6, at a press conference held in Sanming City, Fujian Province, Zhang Yuanming, the deputy mayor of Sanming City, introduced that since the medical reform in Sanming, Fujian, the average life expectancy has increased from 75.
29 years in 2010 to 80.
02 years in 2020
.

The total salary of 22 county-level and above hospitals in the city has increased by 3.

The Sanming Medical Reform will no longer link doctors' income and bonuses with income from medicines and consumables, and greatly increase doctors' sunshine income
.

Increase the treatment level of doctors by increasing the price of medical services, and then reduce the price of medicines and squeeze the water in the circulation of medicines to reduce the expenditure of medical insurance for medicines, so as to ensure the medical insurance funding support used to increase the cost of medical services.

Regarding how to promote the experience of Sanming’s medical reform, Li Bin, deputy director of the National Health Commission and deputy director of the Secretariat of the State Council’s Medical Reform Leading Group, stated at the briefing that he is actively promoting this work in accordance with the deployment of key tasks for the medical reform in 2021 and will work with relevant departments.
Continue to increase the intensity of experience promotion
.

The first is to study and formulate implementation opinions for the in-depth promotion of Sanming’s medical reform experience, put forward real measures to promote Sanming’s experience according to local conditions, clarify timetables, roadmaps, and responsible persons, and specific reform measures can be quantified and assessed to promote Sanming’s medical reform experience.
Flowers and fruits everywhere
.

The second is to make good use of the platform of Sanming City's "National Experience Promotion Base for Deepening the Reform of the Medical and Health System" to organize training regularly and plannedly to increase the promotion and publicity of Sanming's medical reform experience
.

The third is to strengthen supervision and evaluation.
At present, the Sanming Medical Reform Experience Evaluation Index System is being developed and promoted.
Key indicators will be selected to regularly evaluate the work progress and results achieved in various provinces, and the results will be reported to the local party committee and government.
At the same time, all provinces are required It is also necessary to strengthen the guidance and assessment of the local promotion of Sanming's medical reform experience
.

Competitive weapon: price advantage, excellent quality

Sanming Medical Reform resolves the "stubborn disease" of falsely high drug prices, and its heavy blows have always been on drug prices.
For example, on the basis of provincial bidding and procurement, it adopts unified price-limiting purchases in the city, and strictly implements "one product, two regulations" and "two votes".
System" and "Drug Procurement Dean’s Responsibility System"
.

Starting from the price-limiting purchase of drugs in Sanming City, the purchase price of dozens of drugs was more than 50% lower than the provincial bidding price, of which the largest drop reached 96.

Zhang Yuanming said that Sanming’s pharmaceutical reform adopted a volume-based procurement model, which squeezed the falsely high prices in the drug circulation process, and saved a lot of marketing costs.
For the production enterprises, the profit did not decrease.
At the same time, Supporting enterprise development such as medical insurance settlement and advance payment for goods and other supporting measures have solved the problem of payment arrears that has plagued pharmaceutical companies for a long time, and has reduced corporate financial costs
.

Judging from the implementation of centralized procurement by the country, curbing the problem of "selling with gold" at the source has had an obvious positive effect on the pharmaceutical industry: on the one hand, it regulates the order of circulation, improves product quality, and guides the industry in an orderly manner.

With the national promotion of Sanming's medical reform experience and the continuous improvement and normalization of the volume procurement policy, how should pharmaceutical companies adapt to the new competitive landscape?

Experts believe that price advantage and high quality are competitive weapons for pharmaceutical companies
.
Companies must plan and develop innovative drugs; speed up the consistency evaluation process of products to quickly occupy the pharmaceutical market, especially the clinical market and terminal market; look for the main patented products and strive for the first imitation to control the product pricing power; explore competition The well-structured specialty medicines can achieve differentiated competition; expand the scale, improve quality, control costs, improve the level of supply chain management, and win with quality and cost control
.
All in all, as long as companies with key technologies, innovative technologies, and strong comprehensive capabilities, or companies that can successfully develop high-quality generic products, can they have the ability to occupy more advantages in the new competitive landscape of the pharmaceutical market
.